News

March 23, 2012 — New findings from a research study led by Scripps Translational Science Institute (STSI), a collaborative program between Scripps Health and the Scripps Research Institute (TSRI...

March 23, 2012 — Researchers using the VAP (vertical auto profile) Cholesterol Test to isolate lipid subfractions and assess a new anti-flushing agent have reported significant baseline reductions...

March 8, 2012 — Transgenomic Inc. announced the publication of a new study by researchers at Vanderbilt University that further validates the role of both genes found in the company’s PGxPredict:...

March 7, 2012 — Critical Diagnostics announced results from a multi-center study in ambulatory heart failure patients which confirmed that a contemporary panel of biomarkers, including ST2, was...

February 20, 2012 — BG Medicine, Inc. announced positive results from its pivotal validation study for the CardioSCORE diagnostic test, previously known by the development name AMIPredict.

January 30, 2012 — Expanded cholesterol assessment of moderate risk patients can play an important role in identifying and monitoring the progression of atherosclerosis. That’s according to a...

December 14, 2011 — The results of the COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene Expression) trial were presented at the American Heart Association Scientific Sessions...

December 5, 2011 – Roche announced that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany. Verum Diagnostica is a leading...

October 18, 2011 — Randox Laboratories announced the launch of a high sensitivity troponin T control. The new control allows clinical laboratories to more accurately monitor and assess the...

October 4, 2011 – Roche announced plans today to expand its coagulation testing product line in North America beyond physician offices and outpatient clinics with the development of a full line of...

August 30, 2011 – Compared with patients who had persistently high platelet reactivity, those who achieved low platelet reactivity, according to the VerifyNow P2Y12 Test, had a reduced incidence...

August 24, 2011 — Cleveland HeartLab Inc. (CHL), a specialty clinical laboratory and disease management company, announced the completion of an $18.4-million Series B financing round. The rapidly...

August 5, 2011 — BG Medicine Inc., a company specializing in novel, biomarker-based diagnostics, will present results from several studies utilizing its galectin-3 test at the upcoming European...

June 29, 2011 – An industry-first collaboration is bringing together cardiovascular testing company Atherotech Diagnostics Lab and diabetes testing company GlycoMark. The collaboration means the two...
June 20, 2011 — Randox Laboratories, the international clinical diagnostics company, has today launched an automated laboratory assay for heart-type fatty acid binding protein (H-FABP) to improve the...
June 17, 2011 – The new Pathfast cTnI-II (cardiac troponin I) test from Mitsubishi Chemical Medience Corporation has been granted 510(k) premarketing notification clearance by the U.S. Food and Drug...
June 3, 2011 - Research presented at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical...
June 3, 2011 – European CE mark approval was granted to expand use of the VerifyNow point-of-care P2Y12 test platelet reactivity test to identify patients who are poor-responders to antiplatelet...

March 29, 2011 – The U.S. Food and Drug Administration (FDA) cleared a wireless point-of-care testing system that allows real time transmission of diagnostic test results generated directly from...

March 25, 2011 – A new galectin-3 test, recently cleared by the U.S. Food and Drug Administration (FDA) to help assess the prognosis of patients with chronic heart failure, is now offered by...